Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihaela Cristea

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Oncology Nursing Forum|September 7, 2023
Care Processes and Quality-of-Life Outcomes Affecting the Gynecologic Cancer Survivorship ExperienceAnne M Reb, Denice Economou, Diane G Cope, et al.
Frontiers in Oncology|December 27, 2021
PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian CancerAntons Martincuks, Jieun Song, Adrian Kohut, et al.
The Annals of Thoracic Surgery|October 8, 2015
Long-Term Effect of an Interdisciplinary Supportive Care Intervention for Lung Cancer Survivors After Surgical ProceduresDan J Raz, Virginia Sun, Jae Y Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
The impact of lung cancer surgery on quality of life trajectories in patients and family caregiversJae Y Kim, Virginia Sun, Dan J Raz, et al.
Cancer Research Communications|November 30, 2023
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian CancerFerdynand J Kos, Paul Frankel, Mihaela Cristea, et al.
Plos One|June 13, 2023
BRCA germline mutations in multiethnic gynecologic patients: A 10-year retrospective analysis from a single cancer instituteChristina H Wei, Susan Shehayeb, Nicole Lugo Santiago, et al.
Gynecologic Oncology|June 10, 2020
Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 studyErika Hamilton, David M O'Malley, Roisin O'Cearbhaill, et al.
Journal of Pain and Symptom Management|August 23, 2015
Interdisciplinary Palliative Care for Patients With Lung CancerBetty Ferrell, Virginia Sun, Arti Hurria, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Role of Locoregional Treatment in Vulvar Cancer With Pelvic Lymph Node Metastases: Time to Reconsider FIGO Staging?Ashwin Shinde, Richard Li, Arya Amini, et al.
Gynecologic Oncology|January 21, 2018
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignanciesHeidi J Gray, Katherine Bell-McGuinn, Gini F Fleming, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Oncology Nursing Forum|September 7, 2023
Care Processes and Quality-of-Life Outcomes Affecting the Gynecologic Cancer Survivorship ExperienceAnne M Reb, Denice Economou, Diane G Cope, et al.
Frontiers in Oncology|December 27, 2021
PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian CancerAntons Martincuks, Jieun Song, Adrian Kohut, et al.
The Annals of Thoracic Surgery|October 8, 2015
Long-Term Effect of an Interdisciplinary Supportive Care Intervention for Lung Cancer Survivors After Surgical ProceduresDan J Raz, Virginia Sun, Jae Y Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
The impact of lung cancer surgery on quality of life trajectories in patients and family caregiversJae Y Kim, Virginia Sun, Dan J Raz, et al.
Cancer Research Communications|November 30, 2023
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian CancerFerdynand J Kos, Paul Frankel, Mihaela Cristea, et al.
Plos One|June 13, 2023
BRCA germline mutations in multiethnic gynecologic patients: A 10-year retrospective analysis from a single cancer instituteChristina H Wei, Susan Shehayeb, Nicole Lugo Santiago, et al.
Gynecologic Oncology|June 10, 2020
Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 studyErika Hamilton, David M O'Malley, Roisin O'Cearbhaill, et al.
Journal of Pain and Symptom Management|August 23, 2015
Interdisciplinary Palliative Care for Patients With Lung CancerBetty Ferrell, Virginia Sun, Arti Hurria, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Role of Locoregional Treatment in Vulvar Cancer With Pelvic Lymph Node Metastases: Time to Reconsider FIGO Staging?Ashwin Shinde, Richard Li, Arya Amini, et al.
Gynecologic Oncology|January 21, 2018
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignanciesHeidi J Gray, Katherine Bell-McGuinn, Gini F Fleming, et al.
Pageof 6